- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01315561
Motion Style Acupuncture Treatment for Low Back Pain With Severe Disability (MSAT)
November 5, 2018 updated by: Jaseng Hospital of Korean Medicine
Motion Style Acupuncture Treatment for Low Back Pain With Severe Disability: a Randomised, Controlled, Trial Protocol
Motion style acupuncture treatment(MSAT) is a treatment method in which the patient is exposed to active or passive movement and exercise during acupuncture, as opposed to conventional acupuncture.
The purpose of this study is to investigate the effect of MSAT in the treating pain and severe functional disability in acute LBP patients.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
58 patients with acute LBP and severe disability with an Oswestry Disability Index(ODI) of 60% or higher were randomly allocated and divided into 2 groups.
The experimental group was treated with MSAT and the control group was treated with intramuscular injections of diclofenac(NSAID).
All administrations were limited to 1 session, and comparisons were made of measurements before and after treatment.
Primary outcomes were measured by the NRS(numerical rating scale) of back pain in active movement.
Secondary outcomes were measured by the NRS of radiating pain, ODI scores, and the patient's global impression of change(PGIC) etc. Post-treatment follow-up will be performed to measure primary and secondary outcomes with the exception of ROM and SLR at 2, 4, and 24 weeks after treatment.
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bucheon, Korea, Republic of
- Jaseng Oriental Hospital
-
-
Gangnamgu Sinsadong
-
Seoul, Gangnamgu Sinsadong, Korea, Republic of
- Jaseng Oriental Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Acute LBP(with or without leg pain), with onset within past 4 weeks
- Severe disability as assessed by an Oswestry Disability Index of 60% or higher
- Age between 20 and 60
- Given consent to lumbar MRI
- Voluntary participation with written consent given to study consent form
Exclusion Criteria:
- Diagnosis of serious disease(s) which are possible causes of back pain such as malignancy, vertebral fracture, spinal infection, inflammatory spondylitis, cauda equina compression, etc.
- Prior diagnosis of other chronic disease(s) which could affect effectiveness or interpretation of treatment results such as cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, Alzheimer's disease, epilepsy, etc.
- Progressive neurologic deficit(s) or concurrent severe neurological symptoms
- Unsuitable for or at risk of complications from acupuncture treatment such as patients with clotting disorders, severe diabetes with risk of infection, serious cardiovascular disease, or undergoing anticoagulant treatment, etc.
- Under prescription of corticosteroids, immuno-suppressant drugs, psychiatric medicine, or other medication considered unsuitable for subjects by the researcher
- Experience of gastroenteric complications after taking NSAIDs or currently undergoing treatment for digestive disorders
- During pregnancy or suspected pregnancy
- Subjects considered unsuitable for clinical trial by the researcher
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: acupuncture
MSAT is a treatment method in which the patient is exposed to active or passive movement and exercise during acupuncture, as opposed to conventional acupuncture.
|
MSAT and intramuscular injections of diclofenac(NSAID)
|
ACTIVE_COMPARATOR: injections of diclofenac
the control group was treated with intramuscular injections of diclofenac(NSAID).
All administrations were limited to 1 session
|
MSAT and intramuscular injections of diclofenac(NSAID)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from Baseline in numerical rating scale of back pain
Time Frame: Before treatment, At 30 minutes, 2, 4, and 24 weeks after treatment.
|
Before treatment, At 30 minutes, 2, 4, and 24 weeks after treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in NRS of radiating pain, ODI scores, and the patient's global impression of change(PGIC),range of motion (ROM) of the lumbar spine, and degrees of straight leg raising (SLR)
Time Frame: Before treatment, At 30 minutes, 2, 4, and 24 weeks after treatment.
|
Post-treatment follow-up will be performed to measure primary and secondary outcomes with the exception of ROM and SLR at 2, 4, and 24 weeks after treatment.
|
Before treatment, At 30 minutes, 2, 4, and 24 weeks after treatment.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joonshik Shin, JASENG HOSPITAL
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2011
Primary Completion (ACTUAL)
October 1, 2011
Study Completion (ACTUAL)
April 1, 2012
Study Registration Dates
First Submitted
March 14, 2011
First Submitted That Met QC Criteria
March 14, 2011
First Posted (ESTIMATE)
March 15, 2011
Study Record Updates
Last Update Posted (ACTUAL)
November 7, 2018
Last Update Submitted That Met QC Criteria
November 5, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JSR-2011-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complete Immobility Due to Severe Physical Disability
-
Herlev HospitalCompletedRespiratory Tract Infections | Physical Activity | Deglutition Disorders | Impaired Cognition | Complete Immobility Due to FrailtyDenmark
-
Radboud University Medical CenterErasmus Medical Center; Medisch Centrum LeeuwardenRecruitingCancer | Physical Activity | Toxicity Due to Chemotherapy | Systemic TreatmentNetherlands
-
Badr UniversityNot yet recruitingComplete Edentulism Due to Periodontal Disease (Disorder)
-
Charite University, Berlin, GermanyWithdrawnNeed for Renal Replacement Therapy and Anti-infective Therapy Due to Severe InfectionGermany
-
University of BaghdadRecruitingInfertility, Male | Oligospermia | Asthenozoospermia | Infertility Unexplained | Infertility Due to Complete Spermatogenic Arrest | NecrospermiaIraq
-
Centre Hospitalier Metropole SavoieUniversité Savoie Mont BlancNot yet recruitingSarcopenia | Oncology | Toxicity Due to Chemotherapy | Physical Inactivity
-
Central Hospital, Nancy, FranceCompletedARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2France
-
Universidad Pública de NavarraFundacion Miguel Servet; Complejo Hospitalario de NavarraRecruitingMetabolic Syndrome | Exercise | Physical Disability | Health-Related Behavior | Mental Disorders, Severe | Physical Inactivity | Severe Mental Disorder | Mental DeteriorationSpain
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Pain Due to Diabetic PolyneuropathyGermany
-
Centre Hospitalier Universitaire DijonCompletedCOVID-19 Severe Pneumonia | Severe Pneumonia Due to Other PathogeneFrance
Clinical Trials on acupuncture, injection
-
Hospital for Special Surgery, New YorkTerminated
-
Vejle HospitalRegion of Southern Denmark; The A.P. Moller Foundation; The Lillebaelt Hospital...Active, not recruitingMetabolic Syndrome | Shoulder PainDenmark
-
Kyunghee University Medical CenterCompletedIdiopathic Parkinson's DiseaseKorea, Republic of
-
Kyunghee University Medical CenterKyung Hee University Hospital at GangdongCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
Federal University of São PauloCompleted
-
M.D. Anderson Cancer CenterWithdrawn
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown